Michigan had 10 prescriptions per 1,000 residents for the buzzy class of diabetes and anti-obesity drugs like Ozempic and Wegovy last year.
Michigan's rate leads Indiana (8.8 prescriptions per 1,000), Ohio (8.5) and Illinois (5.8), according to insurance claims data provided to Axios by health analytics company PurpleLab.